PCN17 - INDIRECT TREATMENT COMPARISONS OF NIVOLUMAB VERSUS REGORAFENIB, CABOZANTINIB AND BEST SUPPORTIVE CARE AFTER TREATMENT WITH SORAFENIB FOR HEPATOCELLULAR CARCINOMA

Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.099
https://www.valueinhealthjournal.com/article/S1098-3015(18)33399-0/fulltext
Title : PCN17 - INDIRECT TREATMENT COMPARISONS OF NIVOLUMAB VERSUS REGORAFENIB, CABOZANTINIB AND BEST SUPPORTIVE CARE AFTER TREATMENT WITH SORAFENIB FOR HEPATOCELLULAR CARCINOMA
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33399-0&doi=10.1016/j.jval.2018.09.099
First page :
Section Title :
Open access? : No
Section Order : 400
Categories :
Tags :
Regions :
ViH Article Tags :